| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.631 | 14.063 | 13.790 | 13.637 | 9.497 | 7.451 | 14.464 | 16.240 | 9.311 | 3.048 |
| Total Income - EUR | 16.638 | 14.075 | 13.798 | 13.637 | 9.497 | 7.451 | 14.464 | 16.240 | 9.311 | 3.048 |
| Total Expenses - EUR | 8.108 | 7.828 | 8.757 | 9.165 | 9.368 | 6.924 | 4.748 | 6.385 | 3.923 | 4.340 |
| Gross Profit/Loss - EUR | 8.530 | 6.247 | 5.041 | 4.472 | 129 | 527 | 9.716 | 9.855 | 5.388 | -1.292 |
| Net Profit/Loss - EUR | 8.031 | 5.966 | 4.903 | 4.335 | 34 | 412 | 9.448 | 9.568 | 4.572 | -1.292 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Pediatru Homeopat S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92 |
| Current Assets | 4.429 | 6.449 | 11.260 | 15.436 | 14.836 | 14.973 | 24.174 | 33.677 | 4.848 | 3.210 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.416 | 6.430 | 11.251 | 15.429 | 14.801 | 14.879 | 24.081 | 33.530 | 4.253 | 3.049 |
| Cash | 13 | 19 | 9 | 8 | 35 | 94 | 93 | 147 | 595 | 160 |
| Shareholders Funds | 3.982 | 6.019 | 10.820 | 14.958 | 14.702 | 14.836 | 23.954 | 33.596 | 4.620 | 3.302 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 447 | 429 | 440 | 479 | 555 | 138 | 220 | 81 | 228 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Pediatru Homeopat S.r.l.